Contact Congress about H.R. 6434: Freedom to Heal Act of 2025

Some very sick patients could get certain Schedule I experimental drugs through their doctor under Right to Try. Doctors would need a special federal registration, and drug companies would still have to agree to supply the drug.

Modern Action explains legislation in plain English, helps you choose whether to support, oppose, or ask for changes, and drafts a message tied to the bill, your stance, and the elected officials who can act on it.

Freedom to Heal Act of 2025 is a House bill in committee. The latest recorded action: Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Latest action on H.R. 6434: Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Who this affects: This bill mainly affects very sick patients seeking last-option treatment, the doctors who may treat them, and drug companies that control access to these products. It also affects the Justice Department, because the Attorney General would run the registration system and write the rules. State law matters too, so doctors and patients in different states could face different limits.

Why this matters: This bill matters because some very sick patients may want experimental treatment, but Schedule I drugs face extra federal barriers. The bill tries to create a legal path for some of those cases while keeping federal controls in place. It could make access clearer for doctors and patients, but access would still depend on state law, drug company agreement, and future federal rules. The final effect could vary a lot depending on how broad the rules are and how many drugs actually qualify.

Key provisions in H.R. 6434

• Creates a new federal registration for doctors. It would let them give certain Schedule I experimental drugs to patients who qualify under the federal Right to Try law.
• Limits this program to the drugs and patients already defined in section 561B of the Federal Food, Drug, and Cosmetic Act. In other words, it plugs straight into the current Right to Try rules.
• Requires doctors to already hold federal registration for controlled drugs in Schedules II through V. They cannot get this new Schedule I registration first.
• Requires paperwork from the drug maker or sponsor. The paperwork must confirm that the Schedule I drug qualifies and that the company will supply it and give guidance on how to use it.
• Requires proof that state law allows this treatment. Doctors also have to show relevant training, credentials, or experience.

How Modern Action helps you take action on H.R. 6434

You do not have to start with a blank letter. Modern Action turns the bill, your position, and the relevant congressional context into a message you can edit and send. The goal is to make contacting Congress clear, specific, and useful without forcing you to parse bill text or figure out the right office on your own.

Questions people ask about H.R. 6434

What is H.R. 6434?

Some very sick patients could get certain Schedule I experimental drugs through their doctor under Right to Try. Doctors would need a special federal registration, and drug companies would still have to agree to supply the drug.

How do I support or oppose H.R. 6434?

Choose support, oppose, or ask for changes on Modern Action. The action flow drafts the message for you and keeps the wording tied to this bill.

Who should I contact about H.R. 6434?

Modern Action uses your location to route the action to the congressional offices relevant to the bill and your representation.

Can Modern Action explain H.R. 6434 before I act?

Yes. Modern Action gives you a plain-English summary, current status, and action context before you send anything.